\-\ Texto\\:\\ \ \(0\)\
\-\ gen\\:\\ obese\\,\\ aox3\\,\\ sob\\ \\ \\ \\ heent\\:\\ no\\ jvd\\/hjr\\ \\ \\ \\ lungs\\:\\ rhales\\ b\\/l\\,\\ wheezes\\ b\\/l\\ \\ \\ \\ c\\/v\\:\\ rrr\\ no\\ m\\/r\\/g\\ \\ \\ abd\\:\\ soft\\ nt\\/nd\\,\\ nabs\\ \\ \\ \\ \\ ext\\:\\ 2\\+\\ pulses\\,\\ 2\\+\\ pitting\\ tibial\\ edema\\ \\ \\ neuro\\:\\ wnl\\ \\ \\ \\ lymph\\:\\ wnl\ \(0\)\
\-\ the\\ pt\\ spent\\ one\\ week\\ on\\ the\\ general\\ medicine\\ wards\\,\\ requiring\\ 4l\\ 100\\%\\ o2\\ at\\ rest\\.\\ \\ she\\ underwent\\ a\\ vats\\ for\\ lung\\ biopsy\\.\\ \\ she\\ had\\ a\\ difficult\\ post\\-op\\ course\\ characterized\\ by\\ refractory\\ hypotension\\ and\\ severe\\ pulmonary\\ hypertension\\.\\ \\ she\\ spent\\ several\\ weeks\\ in\\ the\\ icu\\ on\\ pressor\\ support\\ and\\ intubated\\,\\ but\\ eventually\\ died\\ from\\ pea\\.\ \(0\)\
\-\ hrct\\ chest\\:\\ peripheral\\/basilar\\ honeycombing\\,\\ irregular\\ intralobular\\ septal\\ thickening\\,\\ irregular\\ interlobular\\ septal\\ thickening\\,\\ patchy\\ ground\\ glass\ \(0\)\
\-\ usual\\ interstitial\\ pneumonia\ \(2\)\
\-\ usual\\ interstitial\\ pneumonia\\,\\ non\\-specific\\ interstitial\\ pneumonia\\,\\ rheumatoid\\ lung\\ dz\\,\\ chronic\\ hypersensitivity\\ pneumonitis\ \(0\)\
\-\ 55\\ year\\ old\\ white\\ female\\ with\\ pmh\\ of\\ htn\\,\\ chf\\,\\ pe\\,\\ anti\\-phoshpolipid\\ antibody\\ syndrome\\,\\ admitted\\ for\\ 3mo\\ hx\\ of\\ sob\\,\\ acutely\\ worsening\\ over\\ past\\ week\\,\\ now\\ with\\ o2\\ saturation\\ of\\ 75\\%\\ at\\ rest\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ spent\\:\\ 0\\.07361832658236789\ \(0\)\
\-\ interstitial\\:\\ 0\\.0685375317333912\ \(0\)\
\-\ b\\/l\\:\\ 0\\.06360422022308751\ \(0\)\
\-\ pneumonia\\:\\ 0\\.05790679828243459\ \(0\)\
\-\ \\:\\:\\ 0\\.055587286032327786\ \(0\)\
\-\ sob\\:\\ 0\\.054501388278441566\ \(0\)\
\-\ usual\\:\\ 0\\.054501388278441566\ \(0\)\
\-\ o2\\:\\ 0\\.053590113863807125\ \(0\)\
\-\ septal\\:\\ 0\\.0508921895148287\ \(0\)\
\-\ jvd\\/hjr\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ c\\/v\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ pressor\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ peripheral\\/basilar\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ anti\\-phoshpolipid\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ 3mo\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ wnl\\:\\ 0\\.04792023634014409\ \(0\)\
\-\ 2\\+\\:\\ 0\\.04779089800520417\ \(0\)\
\-\ wards\\:\\ 0\\.04438454231369701\ \(0\)\
\-\ rest\\:\\ 0\\.04306361858759942\ \(0\)\
\-\ rhales\\:\\ 0\\.042168885985237096\ \(0\)\
\-\ 4l\\:\\ 0\\.04059685280244048\ \(0\)\
\-\ pea\\:\\ 0\\.04059685280244048\ \(0\)\
\-\ intralobular\\:\\ 0\\.039377489134056816\ \(0\)\
\-\ she\\:\\ 0\\.039324362974658564\ \(0\)\
\-\ pitting\\:\\ 0\\.03753884303230156\ \(0\)\
\-\ irregular\\:\\ 0\\.037249690191326554\ \(0\)\
\-\ nt\\/nd\\:\\ 0\\.036809163291183944\ \(0\)\
\-\ nabs\\:\\ 0\\.03616554014552065\ \(0\)\
\-\ vats\\:\\ 0\\.03558979962280029\ \(0\)\
\-\ hrct\\:\\ 0\\.03558979962280029\ \(0\)\
\-\ honeycombing\\:\\ 0\\.03459350696272403\ \(0\)\
\-\ dz\\:\\ 0\\.03415611511751345\ \(0\)\
\-\ aox3\\:\\ 0\\.033751153521045026\ \(0\)\
\-\ interlobular\\:\\ 0\\.033751153521045026\ \(0\)\
\-\ m\\/r\\/g\\:\\ 0\\.03269019169349881\ \(0\)\
\-\ week\\:\\ 0\\.031716015500854955\ \(0\)\
\-\ thickening\\:\\ 0\\.031657099122331715\ \(0\)\
\-\ hypersensitivity\\:\\ 0\\.031038383650477314\ \(0\)\
\-\ pneumonitis\\:\\ 0\\.031038383650477314\ \(0\)\
\-\ antibody\\:\\ 0\\.031038383650477314\ \(0\)\
\-\ acutely\\:\\ 0\\.030368425606256917\ \(0\)\
\-\ chf\\:\\ 0\\.029233784268670883\ \(0\)\
\-\ refractory\\:\\ 0\\.028902502182242277\ \(0\)\
\-\ ext\\:\\ 0\\.028590161123007586\ \(0\)\
\-\ hypotension\\:\\ 0\\.028590161123007586\ \(0\)\
\-\ wheezes\\:\\ 0\\.028152769277797005\ \(0\)\
\-\ \\,\\:\\ 0\\.028106509534581752\ \(0\)\
\-\ icu\\:\\ 0\\.02787948829105022\ \(0\)\
\-\ intubated\\:\\ 0\\.027747807681328576\ \(0\)\
\-\ saturation\\:\\ 0\\.02749359994561878\ \(0\)\
\-\ post\\-op\\:\\ 0\\.027370797454623928\ \(0\)\
\-\ died\\:\\ 0\\.027370797454623928\ \(0\)\
\-\ lung\\:\\ 0\\.02705091934687154\ \(0\)\
\-\ obese\\:\\ 0\\.02701812794021097\ \(0\)\
\-\ glass\\:\\ 0\\.02701812794021097\ \(0\)\
\-\ non\\-specific\\:\\ 0\\.02701812794021097\ \(0\)\
\-\ requiring\\:\\ 0\\.025798764271827312\ \(0\)\
\-\ gen\\:\\ 0\\.02570844021744911\ \(0\)\
\-\ eventually\\:\\ 0\\.02570844021744911\ \(0\)\
\-\ ground\\:\\ 0\\.02570844021744911\ \(0\)\
\-\ htn\\:\\ 0\\.02570844021744911\ \(0\)\
\-\ support\\:\\ 0\\.025035037810760868\ \(0\)\
\-\ patchy\\:\\ 0\\.025035037810760868\ \(0\)\
\-\ abd\\:\\ 0\\.024727098266765613\ \(0\)\
\-\ pulses\\:\\ 0\\.024158848466087755\ \(0\)\
\-\ neuro\\:\\ 0\\.02409179877979369\ \(0\)\
\-\ 75\\:\\ 0\\.023895449002602084\ \(0\)\
\-\ rrr\\:\\ 0\\.023831536217010875\ \(0\)\
\-\ 100\\:\\ 0\\.023583107943367394\ \(0\)\
\-\ characterized\\:\\ 0\\.023230438428954437\ \(0\)\
\-\ pmh\\:\\ 0\\.023230438428954437\ \(0\)\
\-\ hx\\:\\ 0\\.02311776472839304\ \(0\)\
\-\ 55\\:\\ 0\\.022637648030079737\ \(0\)\
\-\ heent\\:\\ 0\\.02258681528329114\ \(0\)\
\-\ medicine\\:\\ 0\\.022149423438080556\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.022056802900846825\ \(0\)\
\-\ \\%\\:\\ 0\\.021784929326185875\ \(0\)\
\-\ tibial\\:\\ 0\\.021573682915360194\ \(0\)\
\-\ pe\\:\\ 0\\.020976965472928544\ \(0\)\
\-\ difficult\\:\\ 0\\.02043904157777416\ \(0\)\
\-\ admitted\\:\\ 0\\.020172428658815515\ \(0\)\
\-\ general\\:\\ 0\\.01967531511670772\ \(0\)\
\-\ lymph\\:\\ 0\\.018849958518823207\ \(0\)\
\-\ hypertension\\:\\ 0\\.018408639630055672\ \(0\)\
\-\ worsening\\:\\ 0\\.018385136450277582\ \(0\)\
\-\ lungs\\:\\ 0\\.017681904906996043\ \(0\)\
\-\ course\\:\\ 0\\.017620390401396947\ \(0\)\
\-\ pt\\:\\ 0\\.017361550571763674\ \(0\)\
\-\ biopsy\\:\\ 0\\.01656662973572\ \(0\)\
\-\ underwent\\:\\ 0\\.016022929155618683\ \(0\)\
\-\ now\\:\\ 0\\.0159623802715937\ \(0\)\
\-\ white\\:\\ 0\\.01548690826618589\ \(0\)\
\-\ several\\:\\ 0\\.015011436260778074\ \(0\)\
\-\ past\\:\\ 0\\.014837155584406743\ \(0\)\
\-\ severe\\:\\ 0\\.014367813115114777\ \(0\)\
\-\ pulmonary\\:\\ 0\\.01364235142196756\ \(0\)\
\-\ syndrome\\:\\ 0\\.013354680747183833\ \(0\)\
\-\ weeks\\:\\ 0\\.013252883917492613\ \(0\)\
\-\ edema\\:\\ 0\\.01320723218268465\ \(0\)\
\-\ chronic\\:\\ 0\\.013152948813699453\ \(0\)\
\-\ one\\:\\ 0\\.012654269854156524\ \(0\)\
\-\ at\\:\\ 0\\.012653149211274677\ \(0\)\
\-\ over\\:\\ 0\\.011888757323169194\ \(0\)\
\-\ soft\\:\\ 0\\.011371184502696995\ \(0\)\
\-\ chest\\:\\ 0\\.011173382513975512\ \(0\)\
\-\ had\\:\\ 0\\.010075682072353596\ \(0\)\
\-\ but\\:\\ 0\\.009959034431877255\ \(0\)\
\-\ female\\:\\ 0\\.009599782904086522\ \(0\)\
\-\ no\\:\\ 0\\.009403761209877617\ \(0\)\
\-\ for\\:\\ 0\\.007968395067133498\ \(0\)\
\-\ on\\:\\ 0\\.007911377184321618\ \(0\)\
\-\ by\\:\\ 0\\.007775250837403687\ \(0\)\
\-\ from\\:\\ 0\\.0069204137330831274\ \(0\)\
\-\ year\\:\\ 0\\.00522461895777549\ \(0\)\
\-\ old\\:\\ 0\\.004781063370831992\ \(0\)\
\-\ a\\:\\ 0\\.004334424063591271\ \(0\)\
\-\ in\\:\\ 0\\.002302717104591557\ \(0\)\
\-\ the\\:\\ 0\\.002266381716452882\ \(0\)\
\-\ and\\:\\ 0\\.0019673115380570323\ \(0\)\
\-\ of\\:\\ 0\\.0019098983737375153\ \(0\)\
\-\ with\\:\\ 0\\.0012787341649168277\ \(0\)\
\-\ \\.\\:\\ 0\\.0009699326802553626\ \(0\)\
